京大:iPS細胞ライセンスをAveryに供与:心筋細胞製造方法(動画):  Kyoto Univ:iPS cell license to Avery: Cardiomyocyte manufacturing method: 京都大学:授予艾利iPS细胞许可:心肌细胞的制造方法

Genetics, Opportunities in Nutrition & Health, disease, IPS, Medical science

COVID-19:阪大が変異ウイルスを人工合成:2週間に短縮(動画):  COVID-19: Osaka Univ synthesizes mutant virus: shortened to 2 weeks:  COVID-19:大阪大学人工合成突变病毒:缩短至2周

Vaccine, Access to Health Care, Medical science, Pharmaceutical

COVID-19:中国製ワクチン、有効性の低さを示唆:CCDC・Gao Fu(動画):   COVID-19: Chinese vaccine, suggesting low efficacy: CCDC / Gao Fu:  COVID-19:中国疫苗,表明疗效低:CCDC /高复

Vaccine, flu, Product Safety & Quality, Access to Health Care, Pharmaceutical

京大:iPSから胎盤細胞を作製:ヒトのナイーブ型iPS細胞(動画):  Kyoto Univ: Making placental cells from iPS: Human naive iPS cells:  京都大学:从iPS制备胎盘细胞:人类幼稚iPS细胞

disease, IPS, Medical science

COVID-19:京大、新型コロナ薬候補発見:raloxifene、 pioglitazone(動画):  COVID-19:Kyoto Univ discovers drug candidate:raloxifene、pioglitazone: COVID-19:京都大学发现新的电晕候选药物:雷洛昔芬和吡格列酮

flu, Access to Health Care, Drugs, IPS, Pharmaceutical

Posts navigation